Gene · 2290
Papers3,284
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,284
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson's disease. | Front Neurosci | 2023 | 37502682 | PubTator, text mining | PubMed |
| Diagnostic yield and novel candidate genes for neurodevelopmental disorders by exome sequencing in an unselected cohort with microcephaly. | BMC Genomics | 2023 | 37501076 | PubTator, text mining | PubMed |
| A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin development. | Nat Commun | 2023 | 37495603 | PubTator, text mining | PubMed |
| Pan-primate studies of age and sex. | Geroscience | 2023 | 37493860 | PubTator, text mining | PubMed |
| Haplotype-level metabarcoding of freshwater macroinvertebrate species: A prospective tool for population genetic analysis. | PLoS One | 2023 | 37486933 | PubTator, text mining | PubMed |
| Influence of type 2 diabetes and obesity on adipose mesenchymal stem/stromal cell immunoregulation. | Cell Tissue Res | 2023 | 37462786 | PubTator, text mining | PubMed |
| A defined roadmap of radial glia and astrocyte differentiation from human pluripotent stem cells. | Stem Cell Reports | 2023 | 37451260 | PubTator, text mining | PubMed |
| Photodynamic Therapy: From the Basics to the Current Progress of N-Heterocyclic-Bearing Dyes as Effective Photosensitizers. | Molecules | 2023 | 37446758 | PubTator, text mining | PubMed |
| Cerebral-Organoid-Derived Exosomes Alleviate Oxidative Stress and Promote LMX1A-Dependent Dopaminergic Differentiation. | Int J Mol Sci | 2023 | 37446226 | PubTator, text mining | PubMed |
Unlocking Neural Function with 3D In Vitro Models: A Technical Review of Self-Assembled, Guided, and Bioprinted Brain Organoids and Their Applications in the Study of Neurodevelopmental and Neurodegenerative Disorders. | Int J Mol Sci | 2023 | 37445940 | PubTator, text mining | PubMed |
| Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition. | Cancers (Basel) | 2023 | 37444447 | PubTator, text mining | PubMed |
| Mechanisms of Regulation of Cryptic Prophage-Encoded Gene Products in Escherichia coli. | J Bacteriol | 2023 | 37439671 | PubTator, text mining | PubMed |
| Protocol for a Wnt reporter assay to measure its activity in human neural stem cells derived from induced pluripotent stem cells. | Curr Res Neurobiol | 2023 | 37426743 | PubTator, text mining | PubMed |
| Molecular mechanisms controlling vertebrate retinal patterning, neurogenesis, and cell fate specification. | Trends Genet | 2023 | 37423870 | PubTator, text mining | PubMed |
| Developmental Pb exposure increases AD risk via altered intracellular Ca2+ homeostasis in hiPSC-derived cortical neurons. | J Biol Chem | 2023 | 37423307 | PubTator, text mining | PubMed |
| Generation of a human Tropomyosin 1 knockout iPSC line. | Stem Cell Res | 2023 | 37422949 | PubTator, text mining | PubMed |
| iProMix: A mixture model for studying the function of ACE2 based on bulk proteogenomic data. | J Am Stat Assoc | 2023 | 37409267 | PubTator, text mining | PubMed |
| Genetic and Protein Network Underlying the Convergence of Rett-Syndrome-like (RTT-L) Phenotype in Neurodevelopmental Disorders. | Cells | 2023 | 37408271 | PubTator, text mining | PubMed |
| Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. | Cell Death Discov | 2023 | 37400464 | PubTator, text mining | PubMed |
| Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke. | Cell Death Discov | 2023 | 37393356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2290/papers?page=15